YOLFTbeta
ScinoPharm Taiwan Ltd

ScinoPharm Taiwan Ltd

1789 · TW · Healthcare / Drug Manufacturers - Specialty & Generic

19.70TWD+0.05 (+0.25%)

Price History

Full chart

Market Stats

Previous Close19.65
Open19.65
Day Range19.50 – 20.05
52-Week Range16.70 – 29.10
Volume568.29K
Market Cap14.67B
P/E (TTM)463.75
Forward P/E40.32
EPS0.04
Dividend Yield1.54%
Beta0.43
50-Day Avg18.98
200-Day Avg20.52

About

ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Li-An Lu
  • Employees0
  • HeadquartersNo. 1, Nan-Ke 8th Road, Tainan City, Taiwan, 741014, Taiwan
  • Websitehttps://www.scinopharm.com

Leadership

  • Mr. Chih-Hsien LoChairman & General Chief Strategy Officer · b. 1957
  • Ms. Li-An LuPresident & CEO
  • Ms. Chih-Hui LinSenior Director of Accounting, Finance & Corporate Governance Officer
  • Mr. Ling-Hsiao LienVice-President of Marketing, Sales & Operations
  • Dr. Li-Chiao Chang Chemistry, Ph.D.VP of R&D Division and Chief Scientific Officer
  • Mr. Jason ChenDirector of Human Resources & Admin
  • Mr. Shun Yang LinDirector of Corporate Development
  • Yao-Hui WangSenior Manager-Division of Accounting

Financials

Income Statement

Currency: TWD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.49B3.15B3.81B3.89B3.95B4.57B5.09B4.10B3.96B4.03B3.52B3.52B2.89B3.08B2.76B3.26B3.19B3.41B3.16B
Growth (%)-+26.35%+21.00%+2.05%+1.61%+15.65%+11.28%-19.46%-3.48%+1.91%-12.76%+0.22%-17.92%+6.57%-10.40%+18.16%-2.39%+6.91%-7.13%
Cost of Revenue1.50B1.57B1.91B1.86B1.97B2.26B2.55B2.50B2.28B2.22B1.97B1.98B1.72B1.77B1.48B2.01B1.97B2.11B2.07B
Gross Profit992.41M1.58B1.90B2.03B1.98B2.31B2.54B1.60B1.68B1.81B1.55B1.54B1.18B1.32B1.28B1.25B1.22B1.30B1.10B
Gross Margin39.79%50.19%49.81%52.27%50.19%50.59%49.97%39.06%42.39%44.80%44.08%43.77%40.67%42.73%46.36%38.32%38.17%38.17%34.66%
Operating Expense351.49M525.34M733.35M811.40M850.99M1.05B1.15B1.04B926.95M937.68M991.20M984.19M909.34M941.96M991.74M845.14M901.50M977.50M987.53M
Operating Income640.92M1.06B1.17B1.22B1.13B1.26B1.40B559.44M749.70M868.28M558.96M558.33M267.07M375.50M288.74M405.63M314.49M322.71M108.91M
Operating Margin25.70%33.52%30.58%31.42%28.67%27.55%27.47%13.65%18.95%21.54%15.90%15.84%9.23%12.18%10.45%12.43%9.87%9.47%3.44%
EBITDA839.27M1.37B1.50B1.57B1.48B1.74B1.86B1.09B1.29B1.29B984.47M964.23M729.46M766.87M690.37M885.34M819.15M909.38M673.97M
EBITDA Margin33.65%43.32%39.35%40.27%37.51%38.05%36.63%26.67%32.71%32.04%28.00%27.36%25.22%24.87%24.99%27.12%25.71%26.70%21.31%
Net Income613.27M872.11M1.04B1.04B959.36M1.17B1.27B484.14M634.97M658.69M422.37M442.98M216.66M282.07M243.47M353.22M287.06M339.35M136.95M
Net Income Margin24.59%27.67%27.30%26.73%24.27%25.61%25.03%11.81%16.05%16.34%12.01%12.57%7.49%9.15%8.81%10.82%9.01%9.96%4.33%
R&D187.34M238.20M327.87M302.19M291.45M303.02M417.88M415.89M324.21M279.57M314.28M313.21M238.37M245.63M305.95M271.26M357.74M459.36M497.28M
R&D as % of Total Revenue7.51%7.56%8.60%7.77%7.37%6.63%8.21%10.15%8.20%6.94%8.94%8.89%8.24%7.97%11.08%8.31%11.23%13.49%15.72%
Interest Expense105.78M83.45M32.65M4.42M108.00K29.00K7.92M4.14M9.02M36.12M76.63M80.17M55.69M15.17M6.55M7.91M9.15M8.08M9.87M
Interest Expense % of Total Revenue4.24%2.65%0.86%0.11%0.00%0.00%0.16%0.10%0.23%0.90%2.18%2.27%1.93%0.49%0.24%0.24%0.29%0.24%0.31%

Balance Sheet

Currency: TWD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.64B5.76B5.82B7.30B9.48B10.34B11.48B11.37B12.22B12.78B12.70B12.56B11.67B11.85B11.69B11.91B11.72B11.94B11.86B
Total Liabilities3.10B2.32B1.35B620.97M920.78M1.27B1.84B1.99B2.36B2.56B2.28B2.02B1.41B1.32B1.18B1.46B1.36B1.42B1.33B
Total Equity2.53B3.44B4.47B6.68B8.57B9.07B9.64B9.38B9.86B10.23B10.42B10.54B10.26B10.53B10.51B10.45B10.36B10.53B10.52B
Cash30.26M173.66M739.63M1.91B3.29B3.04B2.29B1.93B2.34B3.71B3.91B4.20B3.30B4.05B4.08B4.29B3.94B4.17B3.11B
Total Debt2.76B1.96B644.00M3.09M1.05M264.72M690.87M1.28B1.70B1.79B1.69B1.41B697.15M577.35M557.60M677.91M621.10M676.75M762.67M
Net Debt2.73B1.78B-95.64M-1.91B-3.29B-2.77B-1.60B-648.97M-632.40M-1.92B-2.22B-2.79B-2.61B-3.48B-3.52B-3.62B-3.32B-3.49B-2.35B

Cash Flow

Currency: TWD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow504.50M1.41B1.30B1.56B1.29B981.55M939.47M888.29M1.04B1.67B971.71M1.23B788.95M946.31M509.82M773.79M231.13M750.91M597.11M
Investing Cash Flow-63.42M-147.72M-219.87M-602.28M-809.54M-859.91M-1.35B-1.01B-944.17M-202.32M-437.32M-300.00M-98.39M241.72M-69.98M-253.62M-233.29M-293.38M-1.45B
Financing Cash Flow-186.94M-860.28M-1.01B235.38M895.79M-367.64M-355.41M-221.77M305.98M-137.62M-313.91M-627.04M-1.57B-444.91M-412.77M-314.83M-340.98M-244.89M-203.50M
Capital Expenditure82.74M144.62M191.28M405.62M810.14M881.19M1.24B1.02B667.58M458.52M410.93M127.05M105.70M183.10M321.32M250.04M284.71M288.73M291.29M
Free Cash Flow421.75M1.26B1.11B1.16B484.16M100.36M-304.77M-135.44M376.95M1.21B560.79M1.10B683.25M763.22M188.50M523.75M-53.59M462.18M305.82M
Dividends Paid----61.00M631.00M779.92M811.11M140.59M219.32M228.10M379.56M387.46M213.50M395.37M379.56M284.67M237.22M276.76M
FCF to OCF83.60%89.72%85.26%74.07%37.41%10.22%-32.44%-15.25%36.09%72.46%57.71%89.68%86.60%80.65%36.97%67.69%-23.19%61.55%51.22%
Dividend Paid to FCF----12.60%628.72%-255.90%-598.89%37.30%18.18%40.67%34.36%56.71%27.97%209.74%72.47%-531.20%51.33%90.50%

Earnings

Report DateAug 31, 2011Oct 28, 2011Feb 29, 2012Apr 27, 2012Aug 29, 2012Oct 29, 2012Mar 27, 2013May 10, 2013Aug 7, 2013Nov 12, 2013Feb 14, 2014May 9, 2014Aug 7, 2014Nov 10, 2014Mar 29, 2015May 7, 2015Aug 5, 2015Nov 8, 2015Mar 30, 2016May 9, 2016Aug 5, 2016Nov 8, 2016Mar 30, 2017May 5, 2017Aug 2, 2017Nov 5, 2017Feb 14, 2018May 9, 2018Aug 6, 2018Nov 8, 2018Mar 26, 2019May 7, 2019Aug 1, 2019Nov 6, 2019Mar 20, 2020May 10, 2020Aug 12, 2020Nov 6, 2020Mar 18, 2021May 10, 2021Aug 10, 2021Nov 9, 2021Feb 25, 2022May 6, 2022Aug 5, 2022Nov 8, 2022Feb 28, 2023May 10, 2023Aug 7, 2023Nov 7, 2023Feb 26, 2024Feb 25, 2025May 6, 2025Aug 5, 2025Nov 3, 2025Mar 5, 2026
EPS Estimate-0.30-0.22-0.380.43-0.380.52-0.420.400.260.300.120.150.230.250.270.250.240.280.220.230.150.180.160.160.190.170.160.170.100.050.010.010.19-0.070.170.160.150.060.100.110.10--0.080.080.030.040.100.100.13
EPS Actual0.520.320.410.310.220.410.530.440.530.320.330.210.250.150.010.150.170.250.250.210.220.210.180.210.110.140.070.170.170.100.120.100.070.040.060.040.200.100.010.110.110.010.070.100.140.080.130.050.070.040.200.120.060.040.020.05
Surprise-6.67%-40.91%-7.89%23.26%-39.47%-38.46%--50.00%-37.50%-42.31%-96.67%25.00%13.33%8.70%0.00%-22.22%-12.00%-12.50%-35.71%-4.55%-52.17%-6.67%-61.11%6.25%6.25%-47.37%-29.41%-37.50%-58.82%-60.00%20.00%300.00%1900.00%-47.37%-57.14%-35.29%-93.75%-53.33%66.67%40.00%-27.27%30.00%---50.00%150.00%300.00%50.00%-60.00%-80.00%-61.54%
Timing-After-hours-After-hours-After-hoursAfter-hours-After-hoursPre-market-Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market-After-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours

Key Statistics & Ratios

Market Cap14.67B
Enterprise Value12.32B
Trailing P/E463.75
Forward P/E40.32
PEG Ratio6.73
Price / Sales4.78
Price / Book1.43
EPS0.04
Book Value13.23
Revenue (TTM)3.07B
Gross Profit (TTM)905.07M
EBITDA429.00M
Profit Margin1.23%
Operating Margin-9.64%
Return on Equity0.36%
Return on Assets-0.35%
Shares Outstanding790.74M
Shares Float247.24M
Beta0.43
Dividend Yield1.54%
Dividend Rate0.29
Payout Ratio651.41%

Dividends

20231×
0.36Jul 6, 2023
20221×
0.48Jul 7, 2022
20211×
0.50Aug 26, 2021
20201×
0.27Jul 23, 2020
20191×
0.49Jul 25, 2019
20181×
0.48Jul 26, 2018
20171×
0.30Aug 10, 2017
20161×
0.29Aug 10, 2016
20151×
0.18Aug 6, 2015
20141×
1.07Aug 7, 2014
20131×
1.03Aug 8, 2013
20121×
0.82Aug 9, 2012
20111×
0.08Jul 26, 2011

Stock Splits

  • Aug 10, 201726:25
  • Aug 10, 201626:25
  • Aug 6, 201526:25
  • Aug 7, 201426:25
  • Aug 8, 201326:25
  • Aug 9, 2012103:100